More focus is needed on female-specific barriers to enrollment and completion of programs that can improve their outcomes.
Experts continue to debate whether the health status benefits are real and enough to justify doing the procedures for severe ...
In the recent SOUL trial, the GLP-1 drug reduced the risk of MACE by 14% over 4 years. Next up: a possible obesity indication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback